Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
130 participants
OBSERVATIONAL
2024-01-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* How can custom virtual characters (avatars) help to collect more data for the diagnosis of PCS?
* Can conversations with virtual (mobile) characters (avatars) and the presentation of health data help to improve the diagnosis and understanding of PCS?
* How should these virtual characters (avatars) be designed for people with PCS and healthcare professionals to be useful in the long term? This concerns appearance, dialog, personality and functions.
Participants will be asked to use and test the app and take part in two interviews at the beginning and end of the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Co-design of a Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 Using Voice
NCT05546918
Natural History Study of COVID-19 Using Digital Wearables
NCT04927442
Telemedicine in Outpatient Covid-19 Patients
NCT04471636
A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections
NCT04623138
Autonomic Nervous System Affection Due to Post Covid Syndrome
NCT05502094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable clinical condition
* Diagnosis of Post-COVID syndrome according to the World Health Organization (WHO):
* Symptoms persist for more than 12 weeks
* Duration: at least 2 months
* Etiology: no alternative diagnosis
* Progression: persistent, recurrent, fluctuating
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Applied Sciences Cologne
UNKNOWN
Humanizing Technologies GmbH
UNKNOWN
University Hospital of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clara Lehmann
Prof. Dr. Clara Lehmann
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Cologne
Cologne, Northrhine-Westfalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16SV9183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.